Viewing Study NCT06802835


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-04-24 @ 12:38 PM
Study NCT ID: NCT06802835
Status: RECRUITING
Last Update Posted: 2025-05-16
First Post: 2025-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Cancinoma (NPC) View
None Recurrent Nasopharynx Carcinoma View
None Metastatic Nasopharyngeal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR antibody View
None PD-1 antibody View
None chemotherapy View